Please try another search
For the six months ended 31 December 2017, QRxPharma Ltd. revenues decreased 67% to A$2K. Net loss decreased 18% to A$191K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Employee benefit expenses decrease from A$38K (expense) to A$0K, Restructuring expense decrease from A$6K (expense) to A$0K.
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0.01 | 0.01 |
Gross Profit | ||||
Operating Income | -0.19 | -0.18 | -0.24 | -0.58 |
Net Income | -0.19 | -0.19 | -0.23 | -0.54 |
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Assets | 0.45 | 0.65 | 0.87 | 1.27 |
Total Liabilities | -0.04 | -0.03 | -0 | 0.17 |
Total Equity | 0.49 | 0.68 | 0.87 | 1.1 |
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -0.2 | -0.55 | -0.4 | -2.42 |
Cash From Investing Activities | 0 | 0 | 0 | 0 |
Cash From Financing Activities | 0 | 0 | 0 | 0 |
Net Change in Cash | -0.2 | -0.55 | -0.4 | -2.19 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review